Glucose control and vascular complications in veterans with type 2 diabetes

Cited by (1,057)

Items 801–900 of 1,057

1. Diabetes and cardiovascular disease: pathophysiology of a life-threatening epidemic
   Rhodri King, Peter J. Grant · 2016 · Herz
2. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus
   Bianca Hemmingsen, Søren Søgaard Lund, Christian Nyfeldt Gluud, Allan Arthur Vaag, Thomas Almdal, Christina Hemmingsen, Jørn Wetterslev · 2011 · Cochrane Database of Systematic Reviews · Retracted
3. Older type 2 diabetic patients are more likely to achieve glycaemic and cardiovascular risk factors targets than younger patients: analysis of a primary care database
   J. Barrot‐de la Puente, Manel Mata‐Cases, Josep Franch‐Nadal, Xavier Mundet, Aina Casellas, José Manuel Fernández‐Real, Dı́dac Mauricio · 2015 · International Journal of Clinical Practice
4. S2k-Leitlinie Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Alter
   Anke Bahrmann, Philipp Bahrmann, Jeannette Baumann, Jürgen Martin Bauer, Elke Brückel, M. Dreyer, M. Freitag, Alexander Friedl, Stefan Gölz, Susanne Grundke et al. · 2018 · Diabetologie und Stoffwechsel
5. Effect of Glucose Levels on Cardiovascular Risk
   Anastasia Vladimirovna Poznyak, Larisa Sergeevna Litvinova, Paolo Poggio, Vasily N. Sukhorukov, Alexander Nikolaevich Orekhov · 2022 · Cells
6. RANKL–OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy
   Agbor Ndip, Fiona L. Wilkinson, Edward Bernard Jude, Andrew J.M. Boulton, M. Yvonne Alexander · 2014 · Diabetologia
7. Distinct HbA1c trajectories in a type 2 diabetes cohort
   Iris Walraven, M. Ruth Mast, Trynke Hoekstra, A. P. D. Jansen, Amber A. W. A. van der Heijden, Simone P. Rauh, Femke Rutters, Esther van ‘t Riet, Petra J. M. Elders, Annette C. Moll et al. · 2014 · Acta Diabetologica
8. Recent HbA1c Values and Mortality Risk in Type 2 Diabetes. Population-Based Case-Control Study
   Jennifer M. Nicholas, Judith Charlton, Alex Dregan, Martin C. Gulliford · 2013 · PLoS ONE
9. GHb Level and Subsequent Mortality Among Adults in the U.S.
   Sharon Saydah, Min Tao, Giuseppina Imperatore, Edward W. Gregg · 2009 · Diabetes Care
10. Variability in hemoglobin A1c predicts all-cause mortality in patients with type 2 diabetes
    Wen-Ya Ma, Hung‐Yuan Li, Dee Pei, Te‐Lin Hsia, Kuo‐Cheng Lu, Li‐Yu Tsai, Jung‐Nan Wei, Ching‐Chieh Su · 2012 · Journal of Diabetes and its Complications
11. Classification of Diabetes
    Jorge de Faria Maraschin · 2012 · Advances in experimental medicine and biology
12. PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty
    Janice V. Huang, Clifford R. Greyson, Gregory G. Schwartz · 2012 · Journal of Lipid Research
13. Association of Metformin Treatment with Reduced Severity of Diabetic Retinopathy in Type 2 Diabetic Patients
    Yue Li, Christina L. Ryu, Metasebia Munie, Salma Noorulla, Satyesh Rana, Paul Andrew Edwards, Hua Gao, Xiaoxi Qiao · 2018 · Journal of Diabetes Research
14. Prolonged Prothrombotic Effects of Antecedent Hypoglycemia in Individuals With Type 2 Diabetes
    Elaine Chow, Ahmed Iqbal, Emma Walkinshaw, Fladia A. Phoenix, Ian Andrew Macdonald, Robert F. Storey, Ramzi Ajjan, Simon R. Heller · 2018 · Diabetes Care
15. Prevalence and Management of Diabetic Nephropathy in Western Countries
    Bancha Satirapoj, Sharon G. Adler · 2015 · Kidney Diseases
16. Protection from diabetes-induced atherosclerosis and renal disease by d-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice
    Stefano Menini, Carla Iacobini, Pier Carlo Ricci, Claudia Blasetti Fantauzzi, Giuseppe Pugliese · 2014 · Diabetologia
17. Inflammation Determines the Pro-Adhesive Properties of High Extracellular D-Glucose in Human Endothelial Cells In Vitro and Rat Microvessels In Vivo
    Verónica Azcutia, May Ibrahim Abu-Taha, Tania Romacho, Marta Vázquez-Bella, Nuria Matesanz, Francis William Luscinskas, Leocadio Rodríguez‐Mañas, María‐Jesús Sanz, Carlos F. Sánchez‐Ferrer, Concepción Peiró · 2010 · PLoS ONE
18. Early and Intensive Therapy for Management of Hyperglycemia and Cardiovascular Risk Factors in Patients With Type 2 Diabetes
    Dailey, George · 2011 · Clinical Therapeutics
19. Coronary Artery Disease and Diabetes Mellitus
    Doron Aronson, Elazer Reuven Edelman · 2015 · Heart Failure Clinics
20. Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose‐lowering interventions
    Ronan Roussel, Philippe Gabríel Steg, Kamel Mohammedi, Michel Marre, Louis Potier · 2017 · Diabetes Obesity and Metabolism
21. HbA1c method performance: The great success story of global standardization
    Emma English, Erna Lenters‐Westra · 2018 · Critical Reviews in Clinical Laboratory Sciences
22. Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study
    on behalf of the ESCARVAL STUDY GROUP, Jorge Navarro-Pérez, Domingo Orozco‐Beltrán, Vicente Francisco Gil-Guillén, Vicente Pallarés‐Carratalá, Francisco Valls, Antonio García Fernández, Ana María Perez-Navarro, Carlos Sanchís, Alejandro Dominguez-Lucas et al. · 2018 · BMC Cardiovascular Disorders
23. Confirming the bidirectional nature of the association between severe hypoglycemic and cardiovascular events in type 2 diabetes: insights from EXSCEL
    Standl, Eberhard, Stevens, Susanna R., Lokhnygina, Yuliya, Bethel, M. Angelyn, Buse, John B., Gustavson, Stephanie M., Maggioni, Aldo P., Mentz, Robert J., Hernandez, Adrian F., Holman, Rury R. · 2020 · Diabetes Care
24. The impact of cardiovascular co-morbidities and duration of diabetes on the association between microvascular function and glycaemic control
    Francesco Casanova, Damilola D. Adingupu, F. Adams, Kim M. Gooding, Helen C. Looker, Kunihiko Aizawa, Fiona Dove, Salim Elyas, J. J. F. Belch, Phillip E. Gates et al. · 2017 · Cardiovascular Diabetology
25. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial
    Suzanne May Quinn Tan, Yilynn Chiew, Badariah Ahmad, Khalid Abdul Kadir · 2018 · Nutrients
26. Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes – A systematic review and meta-analysis
    Yoshida, Yilin, Joshi, Preeti, Barri, Saba, Wang, Jia, Corder, Amy L., O'Connell, Samantha S., Fonseca, Vivian A. · 2022 · Journal of Diabetes and its Complications
27. Management of Cardiovascular Disease Risk Factors in Older Adults with Type 2 Diabetes Mellitus: 2002–2012 Literature Review
    Gerardo Moreno, Carol M. Mangione · 2013 · Journal of the American Geriatrics Society
28. New Models of Self-Management Education for Minority Ethnic Groups: Pilot Randomized Trial of a Story-Sharing Intervention
    Trisha Greenhalgh, Desirée Campbell-Richards, Shanti Vijayaraghavan, Anna Collard, Farida A Malik, Mark Griffin, Joanne H. Morris, Anne Claydon, Fraser Macfarlane · 2010 · Journal of Health Services Research & Policy
29. Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study
    David R. Webb, Laura J. Gray, Kamlesh Khunti, B. T. Srinivasan, Nicholas A. Taub, S. Campbell, Janette Barnett, Abida Farooqi, Justin Basile Echouffo-Tcheugui, Simon J. Griffin et al. · 2011 · Diabetologia
30. SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases
    Wanner, Christoph, Marx, Nikolaus · 2018 · Diabetologia
31. Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus
    Birgit Fullerton, Andrea Siebenhofer, Klaus Jeitler, Karl Horvath, Thomas Semlitsch, Andrea Berghold, Ferdinand Michael Gerlach · 2018 · Cochrane Database of Systematic Reviews
32. Intensive risk factor management and cardiovascular autonomic neuropathy in type 2 diabetes: the ACCORD trial
    Tang, Yaling, Shah, Hetal, Bueno Junior, Carlos Roberto, Sun, Xiuqin, Mitri, Joanna, Sambataro, Maria, Sambado, Luisa, Gerstein, Hertzel C., Fonseca, Vivian, Doria, Alessandro et al. · 2021 · Diabetes Care
33. Cardiac autonomic regulation and repolarization during acute experimental hypoglycemia in type 2 diabetes
    Chow, Elaine, Bernjak, Alan, Walkinshaw, Emma, Lubina-Solomon, Alexandra, Freeman, Jenny, Macdonald, Ian A., Sheridan, Paul J., Heller, Simon R. · 2017 · Diabetes
34. Incidence and predictors of hypoglycaemia in type 2 diabetes – an analysis of the prospective DiaRegis registry
    Diethelm Tschöpe, Peter Bramlage, Christiane Binz, Michael Krekler, Evelin Deeg, Anselm Kai Gitt · 2012 · BMC Endocrine Disorders
35. Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and wellbeing in insulin-treated patients with diabetes in seven European countries
    Petronella H.L.M. Geelhoed-Duijvestijn, Ulrik Pedersen‐Bjergaard, Raimund Weitgasser, Jorma T. Lahtela, Marie Markert Jensen, Claes‐Göran Östenson · 2013 · Journal of Medical Economics
36. Knowledge of hypoglycemia and its associated factors among type 2 diabetes mellitus patients in a Tertiary Care Hospital in South India
    Vanishree Shriraam, Shriraam Mahadevan, M Anitharani, Nalini Sirala Jagadeesh, SreelekhaBhaskara Kurup, TA Vidya, KrishnaG Seshadri · 2015 · Indian Journal of Endocrinology and Metabolism
37. Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity
    Chunjun Li, Jing Li, Qiu-Mei Zhang, Lin Lv, Rui Chen, Chun-feng Lv, Pei Yu, Demin M. Yu · 2012 · Cardiovascular Diabetology
38. Food and Western Disease Health and Nutrition from an Evolutionary Perspective
    Staffan Lindeberg · 2009
39. Principles and Practice of Nonpharmacological Interventions to Reduce Cardiometabolic Risk
    Samuel E. Dagogo-Jack, Nonso Egbuonu, Chimaroke Edeoga · 2010 · Medical Principles and Practice
40. Diabetes, Insulin Use, and Cancer Risk: Are Observational Studies Part of the Solution–or Part of the Problem?
    Jeffrey A. Johnson, Edwin AM Gale · 2010 · Diabetes
41. Diabetes in Old Age
    Alan J. Sinclair · 2010 · Wiley eBooks
42. Sitagliptin and the risk of hospitalization for heart failure: A population-based study
    Kang-Ling Wang, Chia‐Jen Liu, Tze‐Fan Chao, Chi-Ming Huang, Cheng‐Hsueh Wu, Su‐Jung Chen, Chiu‐Mei Yeh, Tzeng‐Ji Chen, Shing‐Jong Lin, Chern‐En Chiang · 2014 · International Journal of Cardiology
43. Frailty Attenuates the Impact of Metformin on Reducing Mortality in Older Adults with Type 2 Diabetes.
    Chen‐Pin Wang, Carlos Lorenzo, Sara E Espinoza · 2014 · PubMed
44. Adverse events in medicine: Easy to count, complicated to understand, and complex to prevent
    René Amalberti, Dan Benhamou, Yves Auroy, Laurent Degos · 2009 · Journal of Biomedical Informatics
45. International Diabetes Federation: An update of the evidence concerning the prevention of type 2 diabetes
    Rebecca K. Simmons, Nigel C. Unwin, Simon J. Griffin · 2009 · Diabetes Research and Clinical Practice
46. Cardiovascular Disease in Diabetes: Where Does Glucose Fit In?
    Jane E.B. Reusch, Cecilia C. Low Wang · 2011 · The Journal of Clinical Endocrinology & Metabolism
47. Risk of severe hypoglycemia in sulfonylurea‐treated patients from diabetes centers in Germany/Austria: How big is the problem? Which patients are at risk?
    Nanette Cathrin Schloot, Axel Haupt, Morten Schütt, Klaus W. J. Badenhoop, Markus Wolfgang Laimer, Claudia Nicolay, Matthew D. Reaney, Katharina Fink, Reinhard Walter Holl · 2015 · Diabetes/Metabolism Research and Reviews
48. Insulin – Pharmacology, Therapeutic Regimens and Principles of Intensive Insulin Therapy
    Thomas W. Donner, Sudipa Sarkar · 2015 · Europe PMC (PubMed Central)
49. How good is the evidence to support primary care practice?
    Mark H. Ebell, Randi G. Sokol, Aaron Lee, Christopher Simons, Jessica Early · 2017 · BMJ Evidence-Based Medicine
50. Associations of Age at Diagnosis and Duration of Diabetes With Morbidity and Mortality Among Older Adults
    Christine T. Cigolle, Caroline S. Blaum, Chen Lyu, Jinkyung Ha, Mohammed U. Kabeto, Judy Zhong · 2022 · JAMA Network Open
51. Aortic stiffness and cardiovascular risk in type 2 diabetes
    Malek Mansour, Alexandra Yannoutsos, Nilla Majahalme, Davide Agnoletti, Michel E. Safar, Said Ouerdane, Jacques Blacher · 2013 · Journal of Hypertension
52. The importance of glycated haemoglobin (HbA1c) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes
    Pan Chang Yu, Zsolt Bosnyák, Antonio Ceriello · 2010 · Diabetes Research and Clinical Practice
53. Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein
    Romana S. Mughal, Jason L. Scragg, P. Lister, P. Warburton, Kirsten Riches‐Suman, David John O'Regan, Stephen G. Ball, Neil A. Turner, Karen E. Porter · 2010 · Diabetologia
54. Strategies for Optimizing Glycemic Control and Cardiovascular Prognosis in Patients With Type 2 Diabetes Mellitus
    James Henry O’Keefe, Mohammad Abuannadi, Carl J. Lavie, David S.H. Bell · 2011 · Mayo Clinic Proceedings
55. Association of Glycation Gap With Mortality and Vascular Complications in Diabetes
    Ananth Nayak, Alan Michael Nevill, Paul Bassett, Baldev Malkit Singh · 2013 · Diabetes Care
56. Intensive versus conventional glycaemic control for treating diabetic foot ulcers
    Malindu E. Fernando, Ridmee M Seneviratne, Yong Mong Tan, Peter Anthony Lazzarini, Kunwarjit Singh Sangla, Margaret Cunningham, Petra G Buttner, Jonathan Golledge · 2016 · Cochrane Database of Systematic Reviews
57. Self-reported hypoglycemia in insulin-treated patients with diabetes: Results from an international survey on 7289 patients from nine countries
    Rıfat Emral, Faruque Pathan, Carlos Augusto Yepes, Mohamed H. El-Hefnawy, Su‐Yen Goh, Ana María Gómez, Angela Murphy, Salah Abusnana, Achmad Rudijanto, Anand Jain et al. · 2017 · Diabetes Research and Clinical Practice
58. Incidence and Trends in Hypoglycemia Hospitalization in Adults With Type 1 and Type 2 Diabetes in England, 1998–2013: A Retrospective Cohort Study
    Victor W. Zhong, Juhaeri Juhaeri, Stephen R. Cole, Evangelos Kontopantelis, Christina M. Shay, Penny Gordon‐Larsen, Elizabeth J. Mayer‐Davis · 2017 · Diabetes Care
59. Mediation of the effect of glycemia on the risk of CVD outcomes in type 1 diabetes: the DCCT/EDIC study
    Bebu, Ionut, Braffett, Barbara H., Orchard, Trevor J., Lorenzi, Gayle M., Lachin, John M., the DCCT/EDIC Research Group · 2019 · Diabetes Care
60. Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options
    Ching‐Ju Chiu, Ye‐Fong Du, Horng‐Yih Ou, Elizabeth Ann Beverly · 2014 · Clinical Interventions in Aging
61. Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials
    Nayyar Iqbal, Artist Parker, Robert C. Frederich, Mark Donovan, Boaz Hirshberg · 2014 · Cardiovascular Diabetology
62. Targeting pancreatic β cells for diabetes treatment
    Chirag Jain, Md Ansarullah, Sara Bilekova, Heiko Lickert · 2022 · Nature Metabolism
63. Tailoring treatment to the individual in type 2 diabetes practical guidance from theGlobal Partnership for Effective Diabetes Management
    Stefano Del Prato, James R. LaSalle, Stephan Matthaei, Clifford J. Bailey, on behalf of the Global Partnership for Effective Diabetes Management · 2010 · International Journal of Clinical Practice
64. Herbal Medicines and Nutraceuticals for Diabetic Vascular Complications: Mechanisms of Action and Bioactive Phytochemicals
    Eshaifol A. Omara, Antony Kam, Ali Saeed Alqahtani, Kong M. Li, Valentina Razmovski‐Naumovski, Srinivas Nammi, Kelvin Chan, Basil D. Roufogalis, George Qian Li · 2010 · Current Pharmaceutical Design
65. Glycemic Variability: Assessing Glycemia Differently and the Implications for Dietary Management of Diabetes
    Jeannie Tay, Campbell Henry Thompson, Grant David Brinkworth · 2015 · Annual Review of Nutrition
66. Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA
    Dorrin Zarrin Khat, Mansoor Husain · 2018 · Current Diabetes Reports
67. Diabetic Peripheral Neuropathy: Diagnosis and Treatment
    Johan Røikjer, Carsten Dahl Mørch, Niels Ejskjær · 2020 · Current Drug Safety
68. Effects of Hypoglycemia on Cardiovascular Function in Patients with Diabetes
    María Christou, Panagiota A. Christou, Christos Kyriakopoulos, Georgios A. Christou, Stelios K. Tigas · 2023 · International Journal of Molecular Sciences
69. The Risks and Benefits of Implementing Glycemic Control Guidelines in Frail Older Adults with Diabetes Mellitus
    Sei J. Lee, W. John Boscardin, Irena Stijacic Cenzer, Elbert S. Huang, Kathy Rice‐Trumble, Catherine Eng · 2011 · Journal of the American Geriatrics Society
70. Low HbA1c and Increased Mortality Risk-is Frailty a Confounding Factor?
    Ahmed H. Abdelhafiz, Alan J. Sinclair · 2015 · Aging and Disease
71. Predictors and Consequences of Severe Hypoglycemia in Adults with Diabetes - A Systematic Review of the Evidence
    Hanna E. Bloomfield, Nancy L. Greer, David R. Newman, Roderick H. MacDonald, Maureen H. Carlyle, PATRICK J. FITZGERALD, Indulis R. Rutks, Timothy J Wilt · 2012
72. Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control
    S. Akalin, Kerstin E. Berntorp, Antonio Ceriello, A. K. Das, Eric S. Kilpatrick, Teresa Koblik, C. Munichoodappa, Changyu Pan, W. Rosenthall, Marina Vladimirovna Shestakova et al. · 2009 · International Journal of Clinical Practice
73. Optimizing the simultaneous management of blood pressure and cholesterol for type 2 diabetes patients
    Jennifer E. Mason, Brian T. Denton, Nilay D. Shah, Steve Smith · 2013 · European Journal of Operational Research
74. Both High and Low HbA1c Predict Incident Heart Failure in Type 2 Diabetes Mellitus
    Helen Parry, Harshal Deshmukh, Daniel Levin, Natalie Van Zuydam, Douglas H.J. Elder, Andrew D. Morris, Allan D. Struthers, Colin N.A. Palmer, Alex S. F. Doney, Chim Choy Lang · 2015 · Circulation Heart Failure
75. HbA1covertesting and overtreatment among US adults with controlled type 2 diabetes, 2001-13: observational population based study
    Rozalina G. McCoy, Holly K. Van Houten, Joseph S. Ross, Víctor M. Montori, Nilay D. Shah · 2015 · BMJ
76. Blood Sugar Regulation for Cardiovascular Health Promotion and Disease Prevention
    Peter E. H. Schwarz, Patrick Timpel, Lorenz Harst, Colin James Greaves, Mohammed Kumail Ali, Jeffrey D. Lambert, Mary Beth Weber, Mohamad Musbah Almedawar, Henning Morawietz · 2018 · Journal of the American College of Cardiology
77. GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease–A Systematic Review
    Mori, Yusaku, Matsui, Takanori, Hirano, Tsutomu, Yamagishi, Sho-ichi · 2020 · International Journal of Molecular Sciences
78. Prediabetes: The Importance of Early Identification and Intervention
    Willa A. Hsueh, Laurie Orloski, Kathleen Louise Wyne · 2010 · Postgraduate Medicine
79. The Management of Diabetic Neuropathy in CKD
    Rodica Pop‐Busui, Laurel Roberts, Subramaniam Pennathur, Matthias Kretzler, Frank Chip Brosius, Eva L. Feldman · 2009 · American Journal of Kidney Diseases
80. The proarrhythmic effect of hypoglycemia: evidence for increased risk from ischemia and bradycardia
    Charles Nordin · 2013 · Acta Diabetologica
81. The Role of Prestroke Glycemic Control on Severity and Outcome of Acute Ischemic Stroke
    Clara Hjalmarsson, Karin Manhem, Lena Bokemark, Björn Andersson · 2014 · Stroke Research and Treatment
82. Glycated albumin to glycated hemoglobin ratio reflects postprandial glucose excursion and relates to beta cell function in both type 1 and type 2 diabetes
    Yoshifumi Saisho, Kumiko Tanaka, Takayuki Abe, Akira Shimada, Toshihide Kawai, Hiroshi Itoh · 2011 · Diabetology International
83. Predictive Value of the Acute-to-Chronic Glycemic Ratio for In-Hospital Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
    Side Gao, Qingbo Liu, Xiaosong Ding, Hui Chen, Xue-Qiao Zhao, Hongwei Li · 2019 · Angiology
84. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes
    Jonas Ghouse, Jonas Lynggaard Isaksen, Morten Wagner Skov, Bent Lind, Jesper Hastrup Svendsen, Jørgen Kim Kanters, MORTEN SALLING OLESEN, Anders Gaarsdal Holst, Jonas Bille Nielsen · 2019 · Diabetes Obesity and Metabolism
85. Antihyperlipidemic effect of diosmin: A citrus flavonoid on lipid metabolism in experimental diabetic rats
    Subramani Srinivasan, Leelavinothan Pari · 2013 · Journal of Functional Foods
86. Therapeutic Modalities in Diabetic Nephropathy: Standard and Emerging Approaches
    Emaad M. Abdel‐Rahman, Lawand Saadulla, William Brian Reeves, Alaa S. Awad · 2011 · Journal of General Internal Medicine
87. Defining and Achieving Treatment Success in Patients With Type 2 Diabetes Mellitus
    MARK W. STOLAR · 2010 · Mayo Clinic Proceedings
88. Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: the population-based AGES-Reykjavik Study
    Elin Olafsdottir, Thor Aspelund, Gunnar Sigurðsson, Bolli Þórsson, Guðný Eiríksdóttir, Tamara B. Harris, Lenore J. Launer, Rafn Benediktsson, Vilmundur G. Gudnason · 2011 · BMJ Open
89. Calidad de vida y satisfacción con el tratamiento de sujetos con diabetes tipo 2: resultados en España del estudio PANORAMA
    Pedro Luis de Pablos-Velasco, Emilio Salguero Chaves, Julio Mata-Poyo, Beatriz DeRivas-Otero, Ricardo García‐Sánchez, Pablo Viguera-Ester · 2013 · Endocrinología y Nutrición
90. Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus
    Kevin M Goode, Joseph John, Alan S. Rigby, Eric S. Kilpatrick, Stephen Lawrence Atkin, Thanjavur Bragadeesh, Andrew L. Clark, John G.F. Cleland · 2009 · Heart
91. The 2012 SEMDSA Guideline for the Management of Type 2 Diabetes (Revised)
    2012 · Journal of Endocrinology Metabolism and Diabetes of South Africa
92. Heart Failure Considerations of Antihyperglycemic Medications for Type 2 Diabetes
    Eberhard Standl, Oliver Schnell, Darren K. McGuire · 2016 · Circulation Research
93. Type 1 diabetes and periodontitis: prevalence and periodontal destruction—a systematic review
    Ilaria Dicembrini, Lapo Serni, Matteo Monami, Mariasmeralda Caliri, Luigi Barbato, Francesco Cairo, Edoardo Mannucci · 2020 · Acta Diabetologica
94. Association of hypoglycaemia and risk of cardiac arrhythmia in patients with diabetes mellitus: a systematic review and meta-analysis
    Fitzpatrick, Claire, Chatterjee, Sudesna, Seidu, Samuel, Bodicoat, Danielle H., Ng, G Andre, Davies, Melanie J., Khunti, Kamlesh · 2018 · Diabetes, Obesity and Metabolism
95. Effects of intensive glucose lowering in treatment of type 2 diabetes mellitus on cardiovascular outcomes: A meta-analysis of data from 58,160 patients in 13 randomized controlled trials
    Fang, Hong-Juan, Zhou, Yu-Hao, Tian, Yong-Ji, Du, Han-Yang, Sun, Yan-Xia, Zhong, Li-Yong · 2016 · International Journal of Cardiology
96. Canagliflozin, an inhibitor of sodium–glucose cotransporter 2, for the treatment of type 2 diabetes mellitus
    Elizabeth Mary Lamos, Lisa M. Younk, Stephen N. Davis · 2013 · Expert Opinion on Drug Metabolism & Toxicology
97. Cardiovascular safety profile of currently available diabetic drugs.
    Komola Azimova, Zinnia T. San Juan, Debabrata Mukherjee · 2014 · PubMed Central
98. Treating Coronary Disease and the Impact of Endothelial Dysfunction
    Yasushi Matsuzawa, Raviteja Reddy Guddeti, Taek‐Geun Kwon, Lilach O. Lerman, Amir Lerman · 2014 · Progress in Cardiovascular Diseases
99. A systematic review of event rates in clinical trials in diabetes mellitus: The importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design
    David Preiss, Naveed A. Sattar, John J.V. McMurray · 2010 · American Heart Journal
100. Mapping body fat distribution: A key step towards the identification of the vulnerable patient?
     Benoît J. Arsenault, Émilie Pelletier-Beaumont, Jean‐Pierre Després, Éric Larose · 2011 · Annals of Medicine